Congratulations to the EPAD Trial Delivery Centre of the Month: BBRC (Barcelona, Spain)

We are very pleased to announce that the Barcelonabeta Brain Research Center (BBRC) was the most successful trial delivery centre (TDC) in February with 14 newly screened participants in the EPAD Longitudinal Cohort Study (LCS). Congratulations to the entire team (pictured)! The European Prevention of Alzheimer’s Dementia initiative (EPAD) recruited its first Spanish research participant…

EPAD papers identifies expectations related to learning risk status and preferences related to the content, quality, and follow-up of the disclosure process

  Summary: In clinical trials which target pathophysiological mechanisms associated with Alzheimer’s disease, research participants who are recruited based on biomarker test results should be informed about their increased risk of developing Alzheimer’s dementia. This paper presents the results of a qualitative focus group study of attitudes and concerns toward learning information about biomarker-based risk…

EPAD is glad to be featured in the Spanish “Diario Médico” magazine

  On 26 January, the Spanish specialized magazine for physicians “Diario Médico” published an article entitled “Una década de investigación en la prevención del Alzheimer” including an interview of Prof. José Luis Molinuevo, EPAD co-leader and Scientific Director of the BBRC (Barcelonabeta Brain Research Center). BBRC is the institute where the Pasqual Maragall Foundation conducts all…

Interview with Katrin Haeverans

What is your current role in EPAD? As a Janssen employee, I support the EPAD team from an operational perspective. I hope to bring my experience and can help building the EPAD POC platform so that it’s ready to welcome the first Intervention Owners in 2018 and beyond! What did you do prior to joining…

Interview with Joseph Milne

What is your current role in EPAD? I am the project manager for the EPAD Longitudinal Cohort Study (LCS) at IQVIA, formally Quintiles.  As all of the EPAD team will know, IQVIA have very recently been given an enhanced role in the LCS study.  This has given me a much broader scope in the study,…

EPAD Academy has officially started its first activity

The European Prevention of Alzheimer’s Dementia (EPAD) project launched in 2017 its EPAD Academy that is aiming to efficiently leverage EPAD resources to foster and develop academic research capacity and output in Alzheimer’s disease (AD) across Europe for maximum global impact. On January 16, the EPAD Academy held its first activity that is to propose…